{"id":227618,"date":"2026-09-02T13:03:08","date_gmt":"2026-09-02T07:33:08","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=227618"},"modified":"2026-09-02T13:03:12","modified_gmt":"2026-09-02T07:33:12","slug":"is-bikaji-foods-international-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-bikaji-foods-international-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Bikaji Foods International a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"
<\/div>\n

Bikaji Foods International share price around Rs 598. 26.9% below 52-week high of Rs 819. Q1 FY27 revenue Rs 747 crore, up 12.8% YoY. PAT Rs 59 crore, up 1.6%. PE 59x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Bikaji Foods International’s Q1 FY27 results were broadly steady, with revenue at Rs 747 crore and PAT at Rs 59 crore. The Bikaji Foods International share price near Rs 598 has not moved sharply on this print, and investors asking whether Bikaji Foods International is a good buy should look at the underlying margin trend rather than the headline numbers alone.<\/p>\n<\/div>\n

The Bikaji Foods International share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Bikaji Foods International is a packaged snacks and namkeen maker with a growing branded retail presence, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 747 crore, up 12.8% year on year, while profit after tax came in at Rs 59 crore, up 1.6% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Bikaji Foods International share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Bikaji Foods International share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n